FindTrial
Sign In

Metabonomics study of virtual Reality VR assisted trazodone in the treatment of insomnia disorder

Metabonomics study of virtual Reality VR assisted trazodone in the treatment of insomnia disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041872
Enrollment
Unknown
Registered
2021-01-09
Start date
2021-01-05
Completion date
Unknown
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia disorders

Interventions

Health control group:Nil
insomnia disorder group A:drug +VR
insomnia disorder group B:drug

Sponsors

Jiading District Central Hospital affiliated to Shanghai Health Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Clinical evaluation shall be conducted by two trained psychiatrists with the title of attending physician or above, one full-time psychological surveyor conducted scale evaluation; 2. Aged 18-65 years, regardless of gender, junior high school or above, can fill in the questionnaire independently; 3. Patients with informed consent, can cooperate and abide by the treatment agreement.

Exclusion criteria

Exclusion criteria: Organic or medication-induced secondary major depression or bipolar disorder, severe physical or organic mental disorder, severe suicide attempts, paralysis, or other severe history of serious mental disorder: schizophrenia, mental retardation, alcohol or other substance dependence or abuse.

Design outcomes

Primary

MeasureTime frame
Plasma metabolomics;—

Secondary

MeasureTime frame
25-OH-VD3;—

Countries

China

Contacts

Public ContactChen Qing

Jiading District Central Hospital affiliated to Shanghai Health Medical College

qing.chen222@163.com+86 18930869552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026